1. Home
  2. ALK vs RYTM Comparison

ALK vs RYTM Comparison

Compare ALK & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alaska Air Group Inc.

ALK

Alaska Air Group Inc.

HOLD

Current Price

$57.54

Market Cap

6.2B

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$102.78

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALK
RYTM
Founded
1932
2008
Country
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALK
RYTM
Price
$57.54
$102.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
13
Target Price
$70.91
$129.92
AVG Volume (30 Days)
4.0M
657.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.71
$47.98
Revenue Next Year
$6.00
$56.07
P/E Ratio
$68.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.63
$45.91
52 Week High
$78.08
$122.20

Technical Indicators

Market Signals
Indicator
ALK
RYTM
Relative Strength Index (RSI) 59.83 49.11
Support Level $54.41 $95.44
Resistance Level $60.50 $110.93
Average True Range (ATR) 2.74 5.61
MACD 0.12 -0.53
Stochastic Oscillator 70.51 48.51

Price Performance

Historical Comparison
ALK
RYTM

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico, and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements (CPA). The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary and Mileage Plan passenger revenue.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: